Skip to content

Participant login

Track sample status and get your results

Order tests, track orders, and get results

Providers
Patients
- Research Program
- Create Account
- Get Results
- FAQs
- Submit Request
- Diagnostics
- Resources
- FAQs
- Submit Request
Health Systems
- Diagnostic Testing
- Research
Press Releases
The Helix Research Network Adds Three New Health System Members, Transforming Clinical Genomics for Community Benefit
Read More
Life Sciences
Press Releases
Helix Partners with Komodo Health, Combining Helix's Clinico-Genomic Datasets with Komodo's Healthcare Map® for Clinical & Research Impact
Read More
Resources
- Media Library
- Webinars
- Videos
- Podcasts
- News & Press Releases
- In the news
- Press Releases
View All Resources
Videos
Partner Perspectives with Sanford Health
Watch Now
View All Resources
Company

Home
resources

Discover How Helix is Changing the World of Healthcare

Resources Hub

Get in touch

Weaving Genomics into the Fabric of Healthcare

Contact us:

Customer Support: (844) 211 2070 Monday - Friday: 6 AM – 6 PM (Pacific)

© 2016-2025 Helix, Inc. All rights reserved.

Helix, the Helix logo, Exome+, and Sequence Once, Query Often are trademarks of Helix, Inc.

Resources

Blog
Research
All Resources

Who we serve

Health Systems
Life Sciences
Public Health

Company

About Us
News
Press Releases
Careers

Contact Us

Partnerships
Participant Support

Participant Support

Contact Support
Help Center

Privacy Notice
Terms of Service
Notice of Privacy Practices
Consumer Health Privacy Policy
Accessibility
Your Privacy Choices

CLIA #05D2117342
CAP #9382893

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

2

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

3

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

4

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

5

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 7, 2024

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

2

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

3

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

4

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

5

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 7, 2024

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

Genome-wide rare variant analysis for thousands of phenotypes in >70,000 exomes

Research

Oct 17, 2019

Genome-wide rare variant analysis for thousands of phenotypes in >70,000 exomes

ASHG 2019

A genetic retrospective study of Maturity-Onset Diabetes of the Young (MODY) in two population health studies

Research

Oct 16, 2019

A genetic retrospective study of Maturity-Onset Diabetes of the Young (MODY) in two population health studies

The spectrum of mitochondrial genomic variation across 250,000 individuals

Research

Oct 16, 2019

The spectrum of mitochondrial genomic variation across 250,000 individuals

First-line preventative genetic screening: Disease penetrance in Tier 1 inherited diseases in an all-comers population is similar to family history selected populations

Research

Oct 16, 2019

First-line preventative genetic screening: Disease penetrance in Tier 1 inherited diseases in an all-comers population is similar to family history selected populations

Selective constraints and pathogenicity of mitochondrial DNA variants inferred from a novel database of 196,554 unrelated individuals

Research

Oct 8, 2019

Selective constraints and pathogenicity of mitochondrial DNA variants inferred from a novel database of 196,554 unrelated individuals

BIORXIV

Population Health Study Goes Statewide As University Medical Center of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans

Press Releases

May 7, 2019

Population Health Study Goes Statewide As University Medical Center of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans

Helix Expands Focus to Population Health Solutions and Appoints Illumina Veteran Marc Stapley as CEO

Press Releases

Apr 25, 2019

Helix Expands Focus to Population Health Solutions and Appoints Illumina Veteran Marc Stapley as CEO

Helix Expands Focus to Population Health Solutions and Appoints Illumina Veteran Marc Stapley as CEO

Blog

Apr 25, 2019

Helix Expands Focus to Population Health Solutions and Appoints Illumina Veteran Marc Stapley as CEO

Genetic counseling, 2030: An on‐demand service tailored to the needs of a price conscious, genetically literate, and busy world

Research

Mar 8, 2019

Genetic counseling, 2030: An on‐demand service tailored to the needs of a price conscious, genetically literate, and busy world

JOURNAL OF GENETIC COUNSELING

Page 37